2009 Press Releases

• Tranzyme Pharma Enters Into Strategic Drug Discovery Collaboration with Bristol-Myers Squibb

  December 8, 2009

• Tranzyme Pharma Receives FDA Fast Track Status for Its Oral GI Prokinetic Drug Candidate TZP-102

  July 27, 2009

• Tranzyme Pharma CEO Vipin Garg Wins Ernst & Young Entrepreneur Of The Year® Award

  June 23, 2009

• Tranzyme Pharma to Present Multiple Applications of its Proprietary Drug Discovery Technology at the 21st American Peptide Society Symposium

  June 8, 2009

• Tranzyme Pharma CEO Vipin Garg Named Ernst & Young Entrepreneur Of The Year® 2009 Award Finalist in the Carolinas

  May 13, 2009

• Tranzyme Pharma Initiates Dosing in a Phase 2 Study of its Oral Ghrelin Agonist TZP-102 in Patients with Gastroparesis

  May 5, 2009

• Tranzyme Pharma’s Successful Phase 2 Postoperative Ileus Trial Results to be Presented at the American Society of Colon and Rectal Surgeons 2009 Annual Meeting

  May 4, 2009

• Tranzyme Pharma Announces Positive Phase 2 Results with TZP-101 for Improvement of Symptoms in Patients with Gastroparesis

  April 22, 2009

• Tranzyme Pharma to Present at the 27th Annual JP Morgan Healthcare Conference

  January 6, 2009

Archives

• 2009 Press Releases
• 2008 Press Releases
• 2007 Press Releases
• 2006 Press Releases
• 2005 Press Releases
• 2004 Press Releases
• 2003 Press Releases